MIRXES
MiRXES offers discover, develop, and deliver accurate preventive healthcare solutions for cancer, cardiovascular, metabolic and infectious diseases, and make them accessible to all.
MIRXES
Social Links:
Industry:
Biotechnology Health Care Life Science
Founded:
2014-01-01
Status:
Active
Contact:
6779 7340
Email Addresses:
[email protected]
Total Funding:
168 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network Google Universal Analytics
Current Employees Featured
Founder
Investors List
Charoen Pokphand Group
Charoen Pokphand Group investment in Series C - MiRXES
Keytone Ventures
Keytone Ventures investment in Series C - MiRXES
Rock Springs Capital
Rock Springs Capital investment in Series C - MiRXES
CR-CP Life Science Fund
CR-CP Life Science Fund investment in Series C - MiRXES
CCB International
CCB International investment in Series C - MiRXES
New Horizons Venture Capital
New Horizons Venture Capital investment in Series C - MiRXES
CDG Capital
CDG Capital investment in Series C - MiRXES
EDBI
EDBI investment in Series C - MiRXES
EDBI
EDBI investment in Series C - MiRXES
Keytone Ventures
Keytone Ventures investment in Series C - MiRXES
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-03-31 | Med247 | MiRXES investment in Series A - Med247 | 4.5 M USD |
More informations about "MiRXES"
Mirxes | Genomic Services | Next-Generation Sequencing (NGS)
Mirxes provides a range of next-generation sequencing services, delivering the quality data you need, quickly and cost-effectively. Let Mirxes make the most of your genomics data—generated by us or by another sequencing partner—with bioinformatics services tailored to your research …See details»
Homepage - MiRXES
Mirxes Holding Company Limited, a Singapore-headquartered RNA technology company that is making diagnostic solutions for the early detection of diseases accessible on a global scale, …See details»
Setting the Standard in Genomics for Quality & Value
Mirxes provides academic, clinical & agricultural researchers with high-quality, cost-effective genomics sequencing to support discovery of novel diagnostics & therapies.See details»
About - MiRXES
We are a Singapore-headquartered RNA technology company that is a pioneer and leader in developing and commercializing accurate, non-invasive, and affordable blood-based miRNA test kit products for the early detection of …See details»
Mirxes - Crunchbase Investor Profile & Investments
Mirxes is a biotechnology company that discovers, develops, and delivers accurate preventive healthcare solutions for cancer, cardiovascular, metabolic and infectious diseases. The company's mission is to make diagnostic …See details»
Advanced Genomic Services | Quality Data
Mirxes is your trusted partner for a range of genomics services that offer high quality with exceptional value and quick turnaround. Our state-of-the-art facilities and experienced laboratory team provide the reliable, rapid and repeatable …See details»
Pioneering Mirxes Leads Precision Medicine with …
Jun 6, 2024 · Discover how Mirxes, with A*STAR's miRNA technology, pioneers early disease detection and precision medicine, advancing global healthcare.See details»
A*star spin-off Mirxes looking into tests for other …
Dec 20, 2021 · SINGAPORE - Long before Covid-19 struck, local biotech company Mirxes had, for seven years, been developing polymerase chain reaction (PCR) tests to detect cancer. Read more at straitstimes.com.See details»
From Singapore to the world - MiRXES
Founded with a focus on microRNA discoveries and diagnostics, MiRXES is now looking to solidify its manufacturing and delivery capabilities and help Singapore elevate its competitiveness on the global stage.See details»
Biotech firm Mirxes opens South-east Asia's first …
May 27, 2022 · SINGAPORE - Mirxes, a biotechnology company based in Singapore and a spin-off from the Agency for Science, Technology and Research (A*Star), has opened the first Industry 4.0 (i4.0) manufacturing...See details»
Media Release – All - MiRXES
May 24, 2024 · Keep up to date with our latest news and activities as we continue to innovate and develop our science and technology, bringing novel products to market – from Singapore to the World.See details»
Singaporean provider of diagnostic tests and research products …
Jun 1, 2020 · MiRXES is a Singapore-headquartered biotech company providing liquid biopsy diagnostic and precision medicine for early cancer detection, RT-PCR tests for COVID-19, as …See details»
Mirxes - Funding, Financials, Valuation & Investors - Crunchbase
Mirxes is an RNA technology company that develops blood-based miRNA test kits for early disease detection.See details»
From Cancer To Covid-19: How MiRXES Develops 500K Test Kits A …
Jun 11, 2020 · Helping Singapore to flatten the curve is MiRXES, a homegrown biotechnology company co-founded by Dr. Zhou Lihan in 2014. Prior to manufacturing Covid-19 test kits, …See details»
Mirxes | Micro RNA Profiling (miRNA) | Next-Gen Biomarker …
Mirxes offers advanced Micro RNA (miRNA) profiling capabilities to drive next-gen biomarker development and power your discovery and translational research.See details»
MiRxes, Singapore Healthcare Organizations Partner to Develop …
Jul 7, 2022 · NEW YORK – MiRxes, a Singapore-based RNA testing firm, said on Thursday it has signed a memorandum of understanding with several Singapore universities and hospitals to …See details»
Newsroom - MiRXES
May 13, 2024 · Singapore – 11 June 2024 – Mirxes is pleased to announce that our fully-owned subsidiary, Mirxes Japan, has secured a grant of up to 20 million yen (S$172,000) from the …See details»
Infectious Diseases - MiRXES
MiRXES offers complete COVID-19 testing solutions, starting from sample collection and preservation, through easy and reliable RNA extraction, to tested and proven SARS-CoV-2 RT …See details»
Mirxes’ CEO on why it’s HK over SG for its listing - Tech in Asia
Aug 25, 2023 · We look at why Mirxes decided to list in Hong Kong for its IPO and the successful seed round of an Indian generative AI firm.See details»
COVID-19 Testing | Fortitude | MiRXES | Diagnostics
MiRXES offers complete COVID-19 testing solutions, starting from sample collection and preservation, through easy and reliable RNA extraction, to tested and proven SARS-CoV-2 RT …See details»